Advanced Material Development (AMD) has entered into a commercial and technical collaboration with Xyntra Chemicals, a prominent player in the supply, manufacture, and development of polymers. The collaboration aims to develop a range of unique customized latex polymers to support AMD’s colorimetric smart sensing technologies. These polymers will be enhanced by graphene, along with additional nanomaterials.
The immediate priority of the new partnership is to optimize Xyntra’s polymer technology to support the early-stage production of AMD's innovative vaccine vial monitor technology and create the production-ready formula that will enable Xyntra to manufacture the solution at scale under license.
Looking ahead, the partnership’s wider objective is to establish a dominant position in the polymer latex segment for functional photonic crystal-based technologies in various other markets being developed by AMD including novel eye protection systems and cancer diagnostics.
John Lee, CEO of AMD, said: "One of the major challenges in taking any technology from the laboratory into the real world is the ability to scale production. Xyntra’s expertise, scale-up and full-scale production capability of bespoke formulations present our partnership with an outstanding opportunity to bring together these two critical areas and equip our customers with truly cutting-edge innovations., AMD is very excited to be working with Xyntra, together securing the supply chain for current and future customers"
Dr. Bharat Odedra, a Founding Partner of Xyntra, also shared his perspective: "Xyntra are excited to be partnering with AMD who are world leading experts in their field. This collaboration will pave the way for the development of best in class, technologically advanced, and environmentally friendly products, benefiting both people and planet, addressing a range of societal challenges faced by the industries we serve."
